NCT02255305View on ClinicalTrials.gov

FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Clostridium Difficile Infection
Interventions
BIOLOGICAL

FMT

Patients in the FMT group will receive \~50 grams of fecal material suspended in bacteriostatic normal saline and glycerol.

DRUG

Antimicrobials

Patients randomized to the control group will receive antimicrobials targeting C. difficile.

Trial Locations (1)

60201

NorthShore University HealthSystem, Evanston

Sponsors

Lead Sponsor

Endeavor Health
All Listed Sponsors
lead

Endeavor Health

OTHER

NCT02255305 - FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI | Biotech Hunter | Biotech Hunter